Written answers
Thursday, 12 November 2020
Department of Health
Ministerial Correspondence
Brendan Griffin (Kerry, Fine Gael)
Link to this: Individually | In context | Oireachtas source
319. To ask the Minister for Health his views on a matter raised in correspondence by a person (details supplied); and if he will make a statement on the matter. [35834/20]
Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
The HSE has statutory responsibility for decisions on pricing and reimbursement of medicinal products under the community drug schemes in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013.
Gluten-free products were removed from the list of GMS reimbursable items, with a number of other products, in September 2012. These products were, by this time, more widely available and they tend to be significantly cheaper than products sold through community pharmacies. There are no plans to reinstate these products on the list of reimbursable items under the GMS and other community drug schemes.
Coeliac patients may also claim tax relief on medical expenses incurred on gluten-free products manufactured specifically for coeliacs.
No comments